Author:
Zhou Xiang,Lisenko Katharina,Lehners Nicola,Egerer Gerlinde,Ho Anthony D.,Witzens-Harig Mathias
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference22 articles.
1. Coiffier B, Haioun C, Ketterer N et al (1998) Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 92:1927–1932
2. Maloney DG, Liles TM, Czerwinski DK et al (1994) Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 84:2457–2466
3. Prica A, Baldassarre F, Hicks LK et al (2017) Rituximab in lymphoma and chronic lymphocytic leukaemia: a practice guideline. Clin Oncol (R Coll Radiol) 29:e13–e28
4. Shankland KR, Armitage JO, Hancock BW (2012) Non-Hodgkin lymphoma. Lancet 380:848–857
5. Goldman L, Ezzat S, Mokhtar N et al (2009) Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 20:981–987
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献